{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:50:51Z","timestamp":1790257851666,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["UM1AI109565"],"award-info":[{"award-number":["UM1AI109565"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM2AI117870"],"award-info":[{"award-number":["UM2AI117870"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014247","name":"Immune Tolerance Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014247","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ajt.2024.03.007","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T05:31:07Z","timestamp":1710135067000},"page":"1193-1204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Immunosuppression withdrawal in living-donor renal transplant recipients following induction with antithymocyte globulin and rituximab: Results of a prospective clinical trial"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2762-6535","authenticated-orcid":false,"given":"James F.","family":"Markmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7831-7612","authenticated-orcid":false,"given":"Bryna E.","family":"Burrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1407-8795","authenticated-orcid":false,"given":"Jonathan S.","family":"Bromberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6294-5208","authenticated-orcid":false,"given":"Choli","family":"Hartono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3615-0994","authenticated-orcid":false,"given":"Dixon B.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2487-5699","authenticated-orcid":false,"given":"Andrew M.","family":"Possselt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6926-3306","authenticated-orcid":false,"given":"Ali","family":"Naji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1140-5201","authenticated-orcid":false,"given":"Nancy D.","family":"Bridges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8716-4435","authenticated-orcid":false,"given":"Cynthia","family":"Breeden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Kanaparthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7657-4099","authenticated-orcid":false,"given":"Jorge","family":"Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Kopetskie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8330-4701","authenticated-orcid":false,"given":"Noha","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4547-3381","authenticated-orcid":false,"given":"Sindhu","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"528","key":"10.1016\/j.ajt.2024.03.007_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax8863","article-title":"Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawal","volume":"12","author":"Busque","year":"2020","journal-title":"Sci Transl Med"},{"issue":"7","key":"10.1016\/j.ajt.2024.03.007_bib2","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/ajt.12731","article-title":"Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression","volume":"14","author":"Kawai","year":"2014","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.ajt.2024.03.007_bib3","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.humimm.2018.01.007","article-title":"Tolerance induction in HLA disparate living donor kidney transplantation by facilitating cell-enriched donor stem cell Infusion: the importance of durable chimerism","volume":"79","author":"Leventhal","year":"2018","journal-title":"Hum Immunol"},{"issue":"2","key":"10.1016\/j.ajt.2024.03.007_bib4","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/ajt.15086","article-title":"Summary of the third international workshop on clinical tolerance","volume":"19","author":"Kawai","year":"2019","journal-title":"Am J Transplant."},{"key":"10.1016\/j.ajt.2024.03.007_bib5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-065X.2008.00661.x","article-title":"Regulatory B cells as inhibitors of immune responses and inflammation","volume":"224","author":"Bouaziz","year":"2008","journal-title":"Immunol Rev"},{"issue":"12","key":"10.1016\/j.ajt.2024.03.007_bib6","doi-asserted-by":"crossref","first-page":"7868","DOI":"10.4049\/jimmunol.178.12.7868","article-title":"Novel suppressive function of transitional 2 B cells in experimental arthritis","volume":"178","author":"Evans","year":"2007","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"10.1016\/j.ajt.2024.03.007_bib7","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1172\/JCI85113","article-title":"Human regulatory B cells in health and disease: therapeutic potential","volume":"127","author":"Mauri","year":"2017","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.ajt.2024.03.007_bib8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.humimm.2018.02.007","article-title":"Biomarkers of operational tolerance following kidney transplantation \u2013 the immune tolerance network studies of spontaneously tolerant kidney transplant recipients","volume":"79","author":"Newell","year":"2018","journal-title":"Hum Immunol"},{"issue":"11","key":"10.1016\/j.ajt.2024.03.007_bib9","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.2337\/db08-0420","article-title":"Targeting CD22 reprograms B-cells and reverses autoimmune diabetes","volume":"57","author":"Fiorina","year":"2008","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.ajt.2024.03.007_bib10","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1172\/JCI32405","article-title":"Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice","volume":"117","author":"Hu","year":"2007","journal-title":"J\u00a0Clin Invest"},{"issue":"10","key":"10.1016\/j.ajt.2024.03.007_bib11","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.4049\/jimmunol.0801859","article-title":"Novel human transitional B cell populations revealed by B cell depletion therapy","volume":"182","author":"Palanichamy","year":"2009","journal-title":"J\u00a0Immunol"},{"issue":"11","key":"10.1016\/j.ajt.2024.03.007_bib12","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/nm1673","article-title":"B\u00a0lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates","volume":"13","author":"Liu","year":"2007","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.ajt.2024.03.007_bib13","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1432-2277.2006.00388.x","article-title":"Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation","volume":"19","author":"Barth","year":"2006","journal-title":"Transpl Int"},{"issue":"12","key":"10.1016\/j.ajt.2024.03.007_bib14","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1111\/j.1600-6143.2005.01123.x","article-title":"Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression","volume":"5","author":"Flechner","year":"2005","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.ajt.2024.03.007_bib15","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1034\/j.1600-6143.2003.00120.x","article-title":"Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study","volume":"3","author":"Knechtle","year":"2003","journal-title":"Am J Transplant"},{"issue":"19","key":"10.1016\/j.ajt.2024.03.007_bib16","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ajt.2024.03.007_bib17","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: updates and future directions","volume":"8","author":"Solez","year":"2008","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.ajt.2024.03.007_bib18","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/art.21617","article-title":"Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis","volume":"54","author":"Leandro","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.ajt.2024.03.007_bib19","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.2215\/CJN.01070118","article-title":"Peripheral blood B cell depletion after rituximab and complete response in lupus nephritis","volume":"13","author":"Gomez Mendez","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.ajt.2024.03.007_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/ar2798","article-title":"Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response","volume":"11","author":"Nakou","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.ajt.2024.03.007_bib21","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/ajt.12220","article-title":"A\u00a0single dose of rituximab does not deplete B cells in secondary lymphoid organs but alters phenotype and function","volume":"13","author":"Kamburova","year":"2013","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.ajt.2024.03.007_bib22","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1097\/TP.0b013e3181735723","article-title":"B\u00a0cell survival in intragraft tertiary lymphoid organs after rituximab therapy","volume":"85","author":"Thaunat","year":"2008","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.ajt.2024.03.007_bib23","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.immuni.2004.05.010","article-title":"Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches","volume":"20","author":"Thien","year":"2004","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ajt.2024.03.007_bib24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/ejh.12978","article-title":"Effects of rituximab and dexamethasone on regulatory and proinflammatory B-cell subsets in patients with primary immune thrombocytopenia","volume":"100","author":"Gudbrandsdottir","year":"2018","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ajt.2024.03.007_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jneuroim.2015.03.016","article-title":"The immune balance between memory and regulatory B cells in NMO and the changes of the balance after methylprednisolone or rituximab therapy","volume":"282","author":"Quan","year":"2015","journal-title":"J\u00a0Neuroimmunol"},{"issue":"25","key":"10.1016\/j.ajt.2024.03.007_bib26","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1056\/NEJMc0808481","article-title":"B-cell-depleting induction therapy and acute cellular rejection","volume":"360","author":"Clatworthy","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ajt.2024.03.007_bib27","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1600-6143.2005.00759.x","article-title":"Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion","volume":"5","author":"Pearl","year":"2005","journal-title":"Am J Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613524002028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613524002028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T22:28:43Z","timestamp":1762554523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613524002028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1600613524002028"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2024.03.007","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunosuppression withdrawal in living-donor renal transplant recipients following induction with antithymocyte globulin and rituximab: Results of a prospective clinical trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2024.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}